Charles Schwab Investment Management Inc Xoma Corp Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Xoma Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 21,837 shares of XOMA stock, worth $592,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,837

Previous 21,837 -0.0%

Holding current value

$592,437

Previous $517,000 11.8%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$22.31 - $26.7 $50,799 - $60,795	2,277 Added 11.64%	21,837 $517,000
Q2 2023 Aug 09, 2023	BUY	$17.0 - $21.58 $332,520 - $422,104	19,560 New	19,560 $369,000
Q2 2022 Aug 15, 2022	SELL	$17.05 - $28.22 $301,665 - $499,296	-17,693 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$19.62 - $29.61 $7,906 - $11,932	403 Added 2.33%	17,693 $496,000
Q4 2020 Feb 16, 2021	BUY	$19.26 - $45.61 $38,231 - $90,535	1,985 Added 12.97%	17,290 $764,000
Q3 2020 Nov 13, 2020	SELL	$16.25 - $20.94 $16,948 - $21,840	-1,043 Reduced 6.38%	15,305 $289,000
Q2 2020 Aug 14, 2020	BUY	$18.45 - $25.51 $301,620 - $417,037	16,348 New	16,348 $324,000
Q2 2019 Aug 09, 2019	SELL	$11.83 - $18.98 $193,763 - $310,873	-16,379 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.95 - $15.53 $36,196 - $47,040	3,029 Added 22.69%	16,379 $203,000
Q4 2018 Feb 14, 2019	SELL	$11.27 - $17.54 $291,847 - $454,215	-25,896 Reduced 65.98%	13,350 $169,000
Q3 2018 Nov 13, 2018	BUY	$15.67 - $25.73 $141,797 - $232,830	9,049 Added 29.97%	39,246 $690,000
Q2 2018 Aug 08, 2018	BUY	$19.68 - $25.28 $594,276 - $763,380	30,197 New	30,197 $631,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

6.5M

Call Options Held

100

Put Options Held

1.6K

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $311M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Xoma Corp Transaction History